Bryan James to Alzheimer Disease
This is a "connection" page, showing publications Bryan James has written about Alzheimer Disease.
Connection Strength
3.262
-
Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
Score: 0.315
-
Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease. Annu Rev Public Health. 2019 04 01; 40:65-84.
Score: 0.299
-
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
Score: 0.256
-
Author response. Neurology. 2014 Sep 30; 83(14):1302.
Score: 0.222
-
Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014 Mar 25; 82(12):1045-50.
Score: 0.213
-
Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
Score: 0.188
-
Life space and risk of Alzheimer disease, mild cognitive impairment, and cognitive decline in old age. Am J Geriatr Psychiatry. 2011 Nov; 19(11):961-9.
Score: 0.181
-
How do patients with Alzheimer disease rate their overall quality of life? Am J Geriatr Psychiatry. 2005 Jun; 13(6):484-90.
Score: 0.116
-
Identification of Dementia in Medicare Claims Compared to Rigorous Clinical Assessments in African Americans. J Gerontol A Biol Sci Med Sci. 2024 Jan 01; 79(1).
Score: 0.105
-
Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
Score: 0.100
-
Well-Being and Cognitive Resilience to Dementia-Related Neuropathology. Psychol Sci. 2023 03; 34(3):283-297.
Score: 0.098
-
Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. J Am Geriatr Soc. 2002 Dec; 50(12):2019-24.
Score: 0.098
-
Identification of Dementia in Recent Medicare Claims Data, Compared With Rigorous Clinical Assessments. J Gerontol A Biol Sci Med Sci. 2022 06 01; 77(6):1272-1278.
Score: 0.094
-
Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
Score: 0.093
-
Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
Score: 0.092
-
MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
Score: 0.086
-
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimers Dement. 2020 01; 16(1):219-228.
Score: 0.080
-
Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans. Alzheimer Dis Assoc Disord. 2019 Jul-Sep; 33(3):254-259.
Score: 0.077
-
APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
Score: 0.073
-
Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
Score: 0.065
-
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
Score: 0.062
-
Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
Score: 0.059
-
Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 28(2):433-41.
Score: 0.046
-
Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials. Am J Geriatr Psychiatry. 2008 Jul; 16(7):568-74.
Score: 0.036
-
The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008 Mar; 16(3):240-7.
Score: 0.035
-
Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication? Am J Geriatr Psychiatry. 2005 Nov; 13(11):1014-21.
Score: 0.030
-
Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them? Gerontologist. 2005 Jun; 45(3):381-8.
Score: 0.029
-
The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology. 2005 May 10; 64(9):1514-9.
Score: 0.029
-
Why would caregivers not want to treat their relative's Alzheimer's disease? J Am Geriatr Soc. 2003 Oct; 51(10):1391-7.
Score: 0.026
-
Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care. J Geriatr Psychiatry Neurol. 2002; 15(2):68-72.
Score: 0.023
-
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 2021 05; 31(3):e12939.
Score: 0.022
-
Association of financial and health literacy with cognitive health in old age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Mar; 24(2):186-197.
Score: 0.016